SCN5A Variant G1420R

Summary of observed carriers, functional annotations, and structural context for SCN5A G1420R. Data combine curated literature, international cohorts, and gnomAD observations.

Estimated LQT3 penetrance

3%

0/13 effective observations

Estimated BrS1 penetrance

70%

9/13 effective observations

Total carriers

3

3 BrS1 · 0 LQT3 · 0 unaffected

G1420R has not been reported in gnomAD. This residue resides in a Hotspot region for Brugada syndrome and a Non_Hotspot region for LQT3.

Variant features alone are equivalent to phenotyping 6 individuals for Brugada syndrome and 0 individuals for LQT3.

In silico predictors

Variant-level computational predictors.
PROVEAN PolyPhen-2 BLAST-PSSM REVEL Penetrance Density BrS (%) Penetrance Density LQT3 (%)
-7.59 1 -4.79 0.968 92 2

PROVEAN scores below -2 suggest deleterious impact. REVEL scores above 0.5–0.75 are often interpreted as likely pathogenic. PolyPhen-2 scores above 0.85 are typically pathogenic. Penetrance density summarises neighbouring residue risk (Kroncke et al. 2019).

Reported carrier data

Observed carriers by publication or cohort.
Source Year Carriers Unaffected LQT3 BrS1 Other Other Disease
26729854 2016 1 0 1 0
28341781 2017 1 0 1 0
20129283 2010 1 0 1 0
29574140 2018 1 0 1 0
Literature, cohort, and gnomAD 3 0 0 3
Variant features alone 15 9 0 6

Totals may differ from individual publications due to duplicate patients removed during curation.

Functional data

Peak and late/persistent current values are relative to wild-type (100% indicates no change). V1/2 activation and inactivation denote the membrane potentials (mV) at which half-maximal current is achieved.

Published electrophysiology measurements.
PubMed ID Year Cell Type Peak Current (% WT) V1/2 Activation (mV) V1/2 Inactivation (mV) Late/Persistent Current (% WT)
29574140 2018
26729854 2016
28341781 2017
20129283 2010
32533946 2020 HEK 3

Nearby variants

Neighbouring residues within 15 Ångström provide structural context. Variants listed in the right-most column have been observed clinically or in gnomAD.

Previously observed variants near G1420R.
Neighbour residue Distance (Å) Observed variants
901 12 S901L, E901K,
896 12 C896S, C896S,
1417 9
1430 15 D1430N,
1426 11
1453 14
1715 9
1687 13
372 13
1756 15 I1756V,
1429 14
1711 11 c.5131delG,
1450 12
1707 14
1398 12 V1398M,
1411 9
1407 14
1458 14 S1458Y,
1410 12
1706 14 Q1706H, Q1706H,
1716 12 p.L1716SfsX71,
1714 6 D1714G,
376 13 R376C, R376H,
897 13 G897R, G897E, G897R,
1423 5 D1423H,
1721 15
1422 6 M1422R,
1418 8
892 14 F892I,
373 11
1712 8 G1712S, G1712C,
898 9
893 10 R893H, R893C,
1412 11 L1412F,
1719 14
1408 13 G1408R, G1408R,
889 14
1709 15 p.T1709del, T1709R, T1709M,
1420 0 G1420D, G1420P, G1420V, G1420R,
1360 13 F1360C,
1401 13
1425 9
1399 12
1713 10
1454 13
1427 11 A1427S, A1427E,
1424 6 I1424V,
1409 15 Y1409X, Y1409C,
878 11 R878C, R878H, R878L,
1400 8 V1400I,
1421 5
1718 11 S1718R, S1718R, S1718R,
1717 11 L1717P,
1416 10 A1416E, c.4245+1G>C, A1416G, c.4245+2T>A, c.4245+1G>A,
1752 14
879 12 W879R, W879R,
1686 12
375 12
1710 11 S1710L,
1415 7
1428 12 A1428S, A1428V,
1419 5 K1419E,
1414 6 Q1414H, Q1414H,
1402 13
1413 11